Cardiovascular & Hematological Disorders-Drug Targets

Nanoparticle Based Treatment for Cardiovascular Diseases

Volume:19   Issue:1
Pp: 33-44
Purnima Gupta, Evelyn Garcia, Amrita Sarkar, Sumit Kapoor, Khadija Rafiq, Hitendra S. Chand and Rahul Dev Jayant*
DOI: 10.2174/1871529X18666180508113253

Regulation of Smooth Muscle Myosin Light Chain Phosphatase by Multisite Phosphorylation of the Myosin Targeting Subunit, MYPT1

Volume:18   Issue:1
Pp: 4-13
Justin A. MacDonald and Michael P. Walsh*
DOI: 10.2174/1871529X18666180326120638

Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice

Volume:18   Issue:2
Pp: 139-146
Dimitrios Patoulias*, Alexandros Manafis, Christos Mitas, Konstantinos Avranas, Georgios Lales, Ioanna Zografou, Christos Sambanis and Asterios Karagiannis
DOI: 10.2174/1871529X18666180206123149

Immunomodulatory and Anti-inflammatory Effects of Thymoquinone

Volume:18   Issue:1
Pp: 52-60
Hanieh Shaterzadeh-Yazdi, Mohammad-Foad Noorbakhsh, Farzad Hayati, Saeed Samarghandian* and Tahereh Farkhondeh
DOI: 10.2174/1871529X18666180212114816

Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases

Volume:18   Issue:3
Pp: 166-175
Vi T. Dang, Aric Huang and Geoff H. Werstuck*
DOI: 10.2174/1871529X18666180420170108

Glucose Lowering Activity of Anvillea Radiata Coss & Durieu in Diabetic Rats

Volume:18   Issue:1
Pp: 71-80
Morad Hebi and Mohamed Eddouks*
DOI: 10.2174/1871529X18666180223100427

Platelet Activation Polymorphisms in Ischemia

Volume:18   Issue:2
Pp: 153-161
Habib Haybar, Elahe Khodadi, Kazem Zibara and Najmaldin Saki*
DOI: 10.2174/1871529X18666180326121239

Sodium-glucose Cotransporter 2 Inhibitors: Glucose Lowering Against other Hypoglycemic Agents

Volume:18   Issue:2
Pp: 94-103
Konstantinos Avranas*, Konstantinos Imprialos, Konstantinos Stavropoulos, Georgios Lales, Alexandos Manafis, Anastasia Skalkou and Lars Kihm
DOI: 10.2174/1871529X18666180206160838

Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease

Volume:18   Issue:2
Pp: 120-126
Konstantinos Stavropoulos*, Konstantinos P. Imprialos, Nikiforos Stavropoulos, Sofia Bouloukou, Georgios Kerpiniotis, Kyriakos Dimitriadis, Constantinos Tsioufis and Michael Doumas
DOI: 10.2174/1871529X18666180206155349

Buxus sempervirens L. Improves Lipid Profile in Diabetic Rats

Volume:18   Issue:3
Pp: 239-246
Mohammed Ajebli and Mohamed Eddouks*
DOI: 10.2174/1871529X18666180419100823

What Genetics Tells us about Cardiovascular Disease in Diabetic Patients?

Volume:18   Issue:2
Pp: 147-152
Habib Haybar, Mohammad Taha Jalali and Zeinab Deris Zayeri*
DOI: 10.2174/1871529X18666180212114305

Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs

Volume:18   Issue:2
Pp: 104-113
Konstantinos P. Imprialos*, Konstantinos Stavropoulos, Nikiforos Stavropoulos, Dimitrios Patoulias, Konstantinos Petidis, Charalampos Grassos, Kyriakos Dimitriadis and Constantinos Tsioufis
DOI: 10.2174/1871529X18666180206144342

Antihyperglycemic Effect of the Aqueous Extract of Foeniculum vulgare in Normal and Streptozotocin-induced Diabetic Rats

Volume:20   Issue:1
Pp: 54-63
Fadwa El-Ouady, Nadia Lahrach, Mohammed Ajebli, Ahmed E. Haidani and Mohamed Eddouks*
DOI: 10.2174/1871525717666190612121516

Neutrophil Gelatinase-associated Lipocalin as a Marker of Postoperative Acute Kidney Injury Following Cardiac Surgery in Patients with Preoperative Kidney Impairment

Volume:19   Issue:3
Pp: 239-248
N. Tidbury, N. Browning, M. Shaw, M. Morgan , I. Kemp and B. Matata*
DOI: 10.2174/1871529X19666190415115106

Cardiovascular Effects Mediated by Imidazoline Drugs: An Update

Volume:19   Issue:2
Pp: 95-108
Luis Cobos-Puc* and Hilda Aguayo-Morales
DOI: 10.2174/1871529X18666180629170336

Role of AMPK in Diabetic Cardiovascular Complications: An Overview

Volume:19   Issue:1
Pp: 5-13
Karthika Nellaiappan, Veera Ganesh Yerra and Ashutosh Kumar*
DOI: 10.2174/1871529X18666180508104929

Humoral Immunity in Heart Failure

Volume:19   Issue:1
Pp: 14-18
Amrita Sarkar and Khadija Rafiq*
DOI: 10.2174/1871529X18666180518101527

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs

Volume:19   Issue:1
Pp: 51-78
Ota Fuchs*
DOI: 10.2174/1871529X18666180522073855

Connexin43 and Myocardial Ischemia-Reperfusion Injury

Volume:18   Issue:1
Pp: 14-16
Lingyun Zu, Ningxin Wen, Changjie Liu, Mingming Zhao and Lemin Zheng*
DOI: 10.2174/1871529X16666161227143644

Treatment of Chronic Articular Pain in Adult People with Hemophilia

Volume:18   Issue:3
Pp: 182-186
E. Carlos Rodriguez-Merchan*
DOI: 10.2174/1871529X18666180503123412

Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach

Volume:18   Issue:3
Pp: 199-207
Elumalai Suguna*, Rahman Farhana, Elangovan Kanimozhi, Pindigiri Sai Kumar, Govindasamy Kumaramanickavel and Chitralekha Sai Kumar
DOI: 10.2174/1871529X18666180515130136

High Altitude Pulmonary Hypertension

Volume:18   Issue:3
Pp: 187-198
Maurizio Bussotti* and Giovanni Marchese
DOI: 10.2174/1871529X18666180518085245

Sodium-glucose Cotransporter 2 Inhibitors: The Pleiotropic Mechanisms of Actions

Volume:18   Issue:2
Pp: 86-93
Panteleimon Pantelidis*, Andreas Kalliakmanis, Christos Mitas, Michail Sideris, Charalampos Grassos, Andreas Pittaras and Athanasios Manolis
DOI: 10.2174/1871529X18666180206130218

Sodium-glucose Cotransporter 2 Inhibitors: Potential Cardiovascular and Mortality Benefits

Volume:18   Issue:2
Pp: 114-119
Dragan Lovic*, Andreas Pittaras, Manolis Kallistratos, Constantinos Tsioufis, Charalampos Grassos, Dragan Djordjevic, Ivan Tasic and Athanasios Manolis
DOI: 10.2174/1871529X18666180227102137

Sodium-glucose Cotransporter 2 Inhibitors: The Impact on Development and Progression of Heart Failure

Volume:18   Issue:2
Pp: 127-133
Vasilios Papademetriou* and Eleni Geladari
DOI: 10.2174/1871529X18666180405102658